Novo Holdings Valneva Se Call Options Transaction History
Novo Holdings
- $1.15 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VALN
# of Institutions
19Shares Held
4.52MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.46MShares$13.3 Million0.44% of portfolio
-
General American Investors CO Inc354KShares$3.24 Million0.26% of portfolio
-
Wells Fargo & Company San Francisco, CA245KShares$2.24 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il35.7KShares$326,2870.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25.1KShares$229,4820.07% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $631M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...